CXCL10 Is Associated with Increased Cerebrospinal Fluid Immune Cell Infiltration and Disease Duration in Multiple Sclerosis

被引:7
|
作者
Blandford, Stephanie N. [1 ]
Fudge, Neva J. [1 ]
Moore, Craig S. [1 ,2 ]
机构
[1] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF A1B 3V6, Canada
[2] Hlth Sci Ctr, Room HSC4364,300 Prince Philip Dr, St John, NF A1B 3V6, Canada
关键词
multiple sclerosis; cerebrospinal fluid biomarker; CXCL10; immune cell trafficking; immune cell profiling; T-CELLS; CSF; CHEMOKINES; IP-10; SERUM; CXCR3; EXPRESSION; RELEVANT; BLOOD; MCP-1;
D O I
10.3390/biom13081204
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Cerebrospinal fluid (CSF) is an important sampling site for putative biomarkers and contains immune cells. CXCL10 is a multiple sclerosis (MS)-relevant chemokine that is present in the injured central nervous system and recruits CXCR3+ immune cells toward injured tissues. Objective: Perform a comprehensive evaluation to determine a potential relationship between CXCL10 and various immune cell subsets in the CNS of MS and control cases. Methods: In MS and control cases, CXCL10 was measured in the CSF and plasma by ELISA. Immune cells within both the CSF and peripheral blood were quantified by flow cytometry. Results: Compared to non-inflammatory neurological disease (NIND) cases, MS cases had significantly higher CXCL10 in CSF (p = 0.021); CXCL10 was also correlated with total cell numbers in CSF (p = 0.04) and T cell infiltrates (CD3+, p = 0.01; CD4+, p = 0.01; CD8+, p = 0.02); expression of CXCR3 on peripheral immune cell subsets was not associated with CSF CXCL10. Conclusions: Elevated levels of CXCL10 in the CSF of MS cases are associated with increased T cells but appear to be independent of peripheral CXCR3 expression. These results support the importance of elevated CXCL10 in MS and suggest the presence of an alternative mechanism of CXCL10 outside of solely influencing immune cell trafficking.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Phenotyping Cerebrospinal Fluid in Relapsing-Remitting Multiple Sclerosis; CXCL10 identified as an important mediator of immune cell infiltration
    Blandford, S. N.
    Fudge, N.
    Moore, C. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 181 - 182
  • [2] Immunophenotyping human cerebrospinal fluid: CXCL10 and neurofilament light chain levels correlate with CSF immune cell subsets and provide pathophysiological relevance in multiple sclerosis
    Blandford, S.
    Fudge, N.
    Moore, C. S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 766 - 767
  • [3] Increased Plasma CXCL10 May be a Marker of Increased Risk of Immune Restoration Disease Associated With Nonviral Pathogens
    Oliver, Benjamin G.
    Price, Patricia
    Wand, Handan
    French, Martyn A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (03) : E47 - E49
  • [4] CXCL10 is a potential biomarker and associated with immune infiltration in human papillary thyroid cancer
    Qin, Xiao-Jing
    Lin, Xu
    Xue, Gang
    Fan, Hui-Li
    Wang, Hao-Yu
    Wu, Jing-Fang
    Pei, Da
    BIOSCIENCE REPORTS, 2021, 41 (01)
  • [6] Influence of the treatment with methylprednisolone in the expression of the chemokines CXCL10 and CCL2 in serum and cerebrospinal fluid of patients with multiple sclerosis
    Moreira, MA
    Tilbery, CP
    Teixeira, AL
    Monteiro, LP
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S272 - S272
  • [7] CNS recruitment of T helper 1 cells correlates with elevated CXCL10 levels in the cerebrospinal fluid of multiple sclerosis patients
    Gouzouasis, Vasileios
    Markoglou, Nikolaos
    Tsifintaris, Margaritis
    Dagkonaki, Anastasia
    Giannakakis, Antonis
    Anagnostouli, Maria
    Probert, Lesley
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 505 - 505
  • [8] Interleukin 18, chemokines CXCL10 and CXCL13 in the serum and cerebrospinal fluid of patients with relapsing-remitting and primary progressive multiple sclerosis
    Iwanowski, P.
    Kramer, L.
    Wojcicka, M.
    Kaufmann, E.
    Kapica-Topczewska, K.
    Drozdowski, W.
    Losy, J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 149 - 149
  • [9] Increased CXCL10 Is Associated with Reversal Reaction in Leprosy
    Scollard, D. M.
    Martinez, A.
    Chaduvula, M.
    Fowlkes, N.
    Nath, I.
    Stryjewska, B.
    Williams, D. L.
    MODERN PATHOLOGY, 2009, 22 : 297A - 297A
  • [10] Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis
    Moreira, M. A.
    Tilbery, C. P.
    Monteiro, L. P.
    Teixeira, M. M.
    Teixeira, A. L.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (02): : 109 - 113